Balance Sheet
Cash Flow Statement
Beginning Cash BalanceGains from Sales and Divestitures
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Depreciation & Amortization (CF): 2012-2022

Historic Depreciation & Amortization (CF) for RedHill Biopharma (RDHL) over the last 11 years, with Dec 2022 value amounting to $491,000.

  • RedHill Biopharma's Depreciation & Amortization (CF) rose 9.35% to $491,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $2.1 million, marking a year-over-year increase of 11.66%. This contributed to the annual value of $31,000 for FY2024, which is 94.31% down from last year.
  • RedHill Biopharma's Depreciation & Amortization (CF) amounted to $491,000 in Q4 2022, which was down 0.00% from $491,000 recorded in Q3 2022.
  • In the past 5 years, RedHill Biopharma's Depreciation & Amortization (CF) registered a high of $617,000 during Q2 2022, and its lowest value of $22,000 during Q1 2018.
  • In the last 3 years, RedHill Biopharma's Depreciation & Amortization (CF) had a median value of $482,000 in 2020 and averaged $479,917.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first dropped by 15.38% in 2018, then soared by 1,209.09% in 2019.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Depreciation & Amortization (CF) stood at $23,000 in 2018, then surged by 1,000.00% to $253,000 in 2019, then spiked by 86.96% to $473,000 in 2020, then declined by 5.07% to $449,000 in 2021, then climbed by 9.35% to $491,000 in 2022.
  • Its Depreciation & Amortization (CF) stands at $491,000 for Q4 2022, versus $491,000 for Q3 2022 and $617,000 for Q2 2022.